Navigation Links
Weiss Retinal Pick 120 Degree Short

ProductsWeiss Retinal Pick 120 Degree Short
Company Bausch & Lomb Storz
Item Weiss Retinal Pick 120 Degree Short
Features 
Description 0.5 mm short 120 degree angled tip with black ebonized shaft. Titanium handle with position reference indicator. Shaft length 52 mm, handle length 100 mm.
Info Bausch & Lomb Storz
Customer Service: (585) 338-6000

Related medicine products :

1. Weiss Retinal Pick 90 Degree Long
2. Weiss Retinal Pick 120 Degree Long
3. Weiss Retinal Pick 90 Degree Short
4. John Weiss, Eye Spheres
5. Gass Retinal Detachment Hook
6. Olk Angled Retinal Pick - 110 Degree
7. Olk Angled Retinal Pick - 150 Degree
8. Olk Angled Retinal Pick - 130 Degree
9. Olk Angled Retinal Spatula - 110 Degree
10. Olk Angled Retinal Spatula - 150 Degree
11. Olk Angled Retinal Spatula - 130 Degree
The HDR disposable template is designed for single-use to prevent contamination and eliminate the need for cleaning. The template is made with premium silicone molded over a metal frame. This ensures
A sterile, cost-effective solution to eliminating the risk of cross-contamination.
The Reusable Template is designed for use with the Brachystepper® as a guidance system for prostate brachytherapy. Please be sure that the graphics on your software match the graphics on the Reus
...ntroduction in the family of positioners is the EX...form features a top-loading cradle and user-adjust... steeping unit has a digital backlit display monit...er position and a serial data output port for conn...
Medicine Products:
(Date:11/21/2008)...wire-FirstCall/ -- The Providence Service,Corpora...A. Norris, the Company,s,Chief Operating Officer,...ectors. Mr. Norris, appointment fills the vacancy...Geringer and returns the board to six members. Mr...oard. , Mr. Norris, age 41, has been with P...
(Date:11/21/2008)...a novel technique to combat cancer, study says,... Belgian researchers have discovered that some can...d, and this might lead to new treatments that star...ferate, all cells in the body need to produce ener...cess that requires oxygen. Compared with normal ce...
(Date:11/21/2008)...igorously Protect Investment And Restore Sharehold...e-USNewswire/ -- Dr. Stephen Joffe, Craig Joffe, a...chedule 13D with the U.S. Securities and Exchange ...losing ownership of 11.4% of LCA-Vision, Inc. (Nas...ite laser vision correction centers in 33 states i...
(Date:11/21/2008)...swire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NY...overwhelmingly approved the proposals submitted to...Pharmaceuticals Industries Ltd. (Nasdaq: TEVA )....elming support of the transaction by the Barr shar...nd CEO. "We are pleased with the progress that we ...
Breaking Medicine News(10 mins):Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4
... a sister of Indian national Sarabjit Singh who is... that she is out of danger,// and her condition is...suicide attempt in a town in Punjab. Sources repor...ate hospital in the town of Bhikhiwind, which was ...
...ls seek parental consent before carrying out heel-...e a decrease// in the number of babies tested and ...ent report said that hospitals would be better off...of verbal consent prevailing now. "It's important ...
...ating illegal claims for treatment saved ?7.4m las...auds.// The frauds ranged from patients lying to g...gh gold in patients' fillings. A pharmacist invol...ch netted him ?120,000 in payments, was also force...
... his life when some students pushed him from the f... on the floor. Qamar Irfan, a Class 5 student of S...s village, died Thursday. Police said Qamar was fo...y students in a fight over who would sit in the fr...
Other Medicine News:Health News:Doctors Report The Condition Of Sarabijit’s Sister As being Stabl 2
(Date:11/20/2008)...ERRY HILL, N.J., Nov. 20 New Jerse...l water advisory for its customers in the followi... Counties: , , Middlesex County , , ...sex , Piscataway , South Plainfield ... , Bound Brook , Bridgewater , ...
(Date:11/20/2008)... REINACH, Switzerland, November 20 /PRNewswire-Fi...at the Anti-infective Drugs Advisory Committee of ...oted 17 to 2 against the,approval of intravenous ...or,the treatment of patients with complicated ski...ng those caused by methicillin-resistant Staphyloc...
(Date:11/20/2008)... JOLLA, Calif., Nov. 20 ...KA), announced today that it has submitted its,pi...eview under a Special,Protocol Assessment (SPA) p...n,(FDA). , Subject to securing an agreemen...e, prospective, double-blind, placebo-controlled a...
(Date:11/20/2008)...STON, Nov. 20 PAREXEL In...ng global biopharmaceutical services provider, tod... Peru to provide regulatory consulting and clinica...Peru office, PAREXEL now has locations throughout ...America, which also include Argentina, Brazil, Chi...
Breaking Medicine Technology:New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4ISCAR world wide conference on role of culture in human development convenes at UCSD 26042 1ISCAR world wide conference on role of culture in human development convenes at UCSD 26042 2Acupuncture may hold promise for women with hormone disorder 26038 1Acupuncture may hold promise for women with hormone disorder 26038 2New research challenges long held assumptions of flightless bird evolution 4704 1New research challenges long held assumptions of flightless bird evolution 4704 2College Freshmen See Rx Drug Misuse More Risky Than Alcohol Pot 26035 1College Freshmen See Rx Drug Misuse More Risky Than Alcohol Pot 26035 2College Freshmen See Rx Drug Misuse More Risky Than Alcohol Pot 26035 3College Freshmen See Rx Drug Misuse More Risky Than Alcohol Pot 26035 4
...aZeneca today announced that its,collaboration par...rst results from the ARISE (Aggressive Reduction o...tcomes trial which studied,AGI-1067, an investigat...and anti-inflammatory effects, in patients with,co...not meet its primary endpoint of a,statistically s...
...SINESS WIRE)--Mar 19, 2007 - Nymox,Pharmaceutical ...e,results from its newly completed long-term outco...ia (BPH). 26 clinical trial sites,across the U.S. ...inded, placebo controlled study., The study assess...s after NX-1207 treatment. Overall, without furthe...
Other Medicine Technology:Coronary Artery Disease ARISE Trial Showed AGI-1067 Did Not Meet,Primary Endpoint 2Nymox Announces Positive Results from Newly Completed Long-term,Study of NX-1207 for Benign Prostatic Hyperplasia 2Nymox Announces Positive Results from Newly Completed Long-term,Study of NX-1207 for Benign Prostatic Hyperplasia 3